Northwest Biotherapeutics IncAdd to My Watchlist

NWBO:USOTC USIndustry: Therapeutics
  • 0.25
    Last
  • 0.01  -4.00%
    Today's Change
  • 0.26
    Previous Close
  • Today
     
    0.14
    0.98
    52 Week Low - High
8:10 pm ET 7/21/2017
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding192 million
Market Cap$48 million
Return on Equity ttm--
Last DividendNWBO:US does not pay a dividend
Earnings
EPS: Year Actual ttm-0.732
EPS: Year Est. 12/17 ttm--
 
EPS: Quarterly Actual -- -0.07
EPS: Quarterly Est. -- --
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate47.97
Company Description
Northwest Biotherapeutics, Inc., a biotechnology company, discovers, develops, and commercializes immunotherapy products. The Company's products generate and enhance immune system responses to treat cancer. The DCVax product candidate platform creates cancer immunotherapies.
Revenue$623,000
Net Income$-80 million
Total Assets$53 million
Employees10
Web Sitewww.nwbio.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!